This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Jayaprakash Nair, PhD
Senior Director, Chemistry and Delivery Science at Alnylam Pharmaceuticals


Dr. Jayaprakash (Jay) Nair joined Alnylam Pharmaceuticals in 2005 where he currently serves as Senior Director, Chemistry & Delivery Science, Research heading the Medicinal Chemistry group focused on RNAi platform and siRNA delivery. In this role, Dr. Nair has contributed to the development of GalNAc conjugates and lipid nanoparticles, two clinically validated platforms for siRNA delivery, and the advancement of multiple therapeutic programs to development, which culminated in multiple approval of RNAi therapeutics ONPATTROTM, GIVLAARITM and OXLUMO™. He is also currently co-leading RNAi platform delivery efforts with focus to develop extra-hepatic platform for CNS, Ocular, Muscle and Kidney.

Jay received his Ph.D. in Organic Chemistry in 2000 at the National Chemical Laboratory, Pune, India. He moved to the U.S. for his postdoctoral research at North Carolina State University and Natural Product and Glycotechnology Research (NPG) Institute where he worked novel chemistries, oligosaccharide synthesis and characterization.

During Jay’s almost 17 years of experience in the field of oligonucleotide therapeutics, he has contributed to siRNA delivery and advancement of RNAi platform. He is the author of more than 50 peer-reviewed scientific publications, reviews, and inventor on more than 40 issued patents or patent applications.

Agenda Sessions

  • Oligonucleotide Chemistry and Delivery